Pharmaceutical preparations Sample Contracts

EXHIBIT B
Registration Rights Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
THE ELIGIBLE SUBSIDIARIES REFERRED TO HEREIN, AS BORROWERS
Credit Agreement • April 4th, 2006 • Allergan Inc • Pharmaceutical preparations • New York
CONFIDENTIAL STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • August 14th, 2001 • Sicor Inc • Pharmaceutical preparations
INDENTURE
Indenture • November 3rd, 2006 • Celgene Corp /De/ • Pharmaceutical preparations • New York
RECITALS
Distribution Agreement • November 18th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
WITNESSETH:
Lease Agreement • January 27th, 2005 • Sinofresh Healthcare Inc • Pharmaceutical preparations • Florida
PART II AMENDMENTS TO CREDIT AGREEMENT
Credit Agreement • November 22nd, 2006 • Chattem Inc • Pharmaceutical preparations
Recitals
Escrow Agreement • September 8th, 2004 • Vital Living Inc • Pharmaceutical preparations • New York
EXHIBIT 4.1 IMPAX LABORATORIES, INC. 3.50% CONVERTIBLE SENIOR SUBORDINATED DEBENTURES DUE 2012 PURCHASE AGREEMENT
Purchase Agreement • June 27th, 2005 • Impax Laboratories Inc • Pharmaceutical preparations • New York
SERIES I COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.
Security Agreement • June 13th, 2025 • Palatin Technologies Inc • Pharmaceutical preparations • New York

This SERIES I COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Shareholder Approval Date (as defined below) (the “Initial Exercise Date”), and on or prior to 5:00 p.m. (New York City time) on the Termination Date (as defined herein) but not thereafter, to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to [●] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one Warrant Share shall be equal to the Exercise Price, as defined in Section 2(b).

AGREEMENT
Pledge Agreement • February 14th, 2006 • Global Resource CORP • Pharmaceutical preparations • California
AGREEMENT
Management Agreement • March 25th, 1999 • Columbia Laboratories Inc • Pharmaceutical preparations • Delaware
BIOVAIL CORPORATION, as Issuer,
First Supplemental Indenture • May 21st, 2002 • Biovail Corp International • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT GEOVAX LABS, INC.
Common Stock Purchase Warrant • June 16th, 2025 • GeoVax Labs, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [-] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the fifth (5th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from GeoVax Labs, Inc., a Delaware corporation (the “Company”), up to [-] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

VIRBAC CORPORATION FORM 10-Q SEPTEMBER 30, 2003
Stock Purchase Agreement • May 6th, 2005 • Virbac Corp • Pharmaceutical preparations • Delaware
RECITALS
Loan and Security Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • California
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 16th, 2025 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of ______, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

PART II AMENDMENTS TO CREDIT AGREEMENT
Credit Agreement • April 1st, 2005 • Chattem Inc • Pharmaceutical preparations
and
Merger Agreement • October 30th, 2007 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXECUTION VERSION AGREEMENT AND PLAN OF MERGER
Merger Agreement • July 18th, 2008 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • Delaware
UNDERWRITING AGREEMENT UNDERWRITING AGREEMENT
Underwriting Agreement • January 17th, 2006 • Valera Pharmaceuticals Inc • Pharmaceutical preparations • New York